QA: VACCINEX INC. in us_pharma/2022

Table of Contents

See also this year's filing and all EDGAR filings for this company.

PDF Report 0001205922_2023_VACCINEX_INC.pdf

Logs

info NetIncome node detected by tax heuristic input.sec.calculation_linkbase.edgar_model_mapping {'net_inc_node': 'ComprehensiveIncomeNetOfTax'}

Graph

Absolute values for 0001205922, VACCINEX INC.

  xvar xval
0 AssetsCurrent 7,478,000
1 IntangibleAssetsNetIncludingGoodwill 0
2 PropertyPlantAndEquipmentNet 189,000
3 remainder_Assets 310,000
4 LiabilitiesCurrent 2,537,000
5 LiabilitiesNoncurrent 247,000
6 remainder_Liabilities 0
7 CostOfGoodsAndServicesSold 0
8 SellingGeneralAndAdministrativeExpense 6,202,000
9 ResearchAndDevelopmentExpense 13,979,000
10 remainder_Expenses 2,000
11 remainder_Revenues 275,000
12 remainder_NetIncome 93,000
13 remainder_ComprehensiveNetIncome -19,815,000
  yvar yval
0 Assets 7,977,000
1 Liabilities 2,784,000
2 Expenses 20,183,000
3 Revenues 275,000
4 StockholdersEquity 5,193,000
5 NetIncome -19,815,000
6 ComprehensiveNetIncome -29,722,500
7 BaseVar 25,563,500
8 EconomicCapitalRatio -3.86

Edgar->Model Mapping

Feature Distribution

Change over Time